EA201171001A1 - Пептиды трав для вакцины - Google Patents

Пептиды трав для вакцины

Info

Publication number
EA201171001A1
EA201171001A1 EA201171001A EA201171001A EA201171001A1 EA 201171001 A1 EA201171001 A1 EA 201171001A1 EA 201171001 A EA201171001 A EA 201171001A EA 201171001 A EA201171001 A EA 201171001A EA 201171001 A1 EA201171001 A1 EA 201171001A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptides
herbal
vaccine
allergies
prevention
Prior art date
Application number
EA201171001A
Other languages
English (en)
Other versions
EA020792B1 (ru
Inventor
Род Хэфнер
Пол Лэйдлер
Гай Лейтон
Марк Лярш
Original Assignee
Серкешиа Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0901927.4A external-priority patent/GB0901927D0/en
Priority claimed from GB0901928A external-priority patent/GB0901928D0/en
Priority claimed from GB0912578A external-priority patent/GB0912578D0/en
Priority claimed from PCT/GB2009/001995 external-priority patent/WO2010018384A1/en
Priority claimed from GB0917871A external-priority patent/GB0917871D0/en
Application filed by Серкешиа Лимитед filed Critical Серкешиа Лимитед
Publication of EA201171001A1 publication Critical patent/EA201171001A1/ru
Publication of EA020792B1 publication Critical patent/EA020792B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)

Abstract

Изобретение относится к композициям, включающим пептиды, для профилактики или лечения аллергии на клещей домашней пыли и, в особенности, к оптимальным комбинациям пептидов для профилактики или лечения указанной аллергии.
EA201171001A 2009-02-05 2010-02-05 Пептиды трав для вакцины EA020792B1 (ru)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB0901927.4A GB0901927D0 (en) 2009-02-05 2009-02-05 Peptide for IL10 production
GB0901928A GB0901928D0 (en) 2009-02-05 2009-02-05 Peptides for vaccine
GB0912578A GB0912578D0 (en) 2009-07-20 2009-07-20 Peptide for IL-10 production
PCT/GB2009/001995 WO2010018384A1 (en) 2008-08-15 2009-08-14 T-cell antigen peptide from allergen for stimulation of il-10 production
GB0917871A GB0917871D0 (en) 2009-10-12 2009-10-12 Peptides for vaccine
PCT/GB2010/000198 WO2010089554A1 (en) 2009-02-05 2010-02-05 Peptides for vaccine

Publications (2)

Publication Number Publication Date
EA201171001A1 true EA201171001A1 (ru) 2012-02-28
EA020792B1 EA020792B1 (ru) 2015-01-30

Family

ID=42082585

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201171001A EA020792B1 (ru) 2009-02-05 2010-02-05 Пептиды трав для вакцины

Country Status (23)

Country Link
US (2) US8753644B2 (ru)
EP (2) EP2891662A1 (ru)
JP (2) JP5746053B2 (ru)
KR (1) KR20110111307A (ru)
CN (2) CN103784952B (ru)
AU (1) AU2010212193B2 (ru)
BR (1) BRPI1008802A2 (ru)
CA (1) CA2751500A1 (ru)
DK (1) DK2393830T3 (ru)
EA (1) EA020792B1 (ru)
ES (1) ES2532759T3 (ru)
GB (1) GB2469894B (ru)
HK (1) HK1212358A1 (ru)
HR (1) HRP20150317T1 (ru)
IL (1) IL214257A (ru)
MX (1) MX2011008179A (ru)
NZ (1) NZ594268A (ru)
PL (1) PL2393830T3 (ru)
PT (1) PT2393830E (ru)
SG (1) SG173523A1 (ru)
SI (1) SI2393830T1 (ru)
WO (1) WO2010089554A1 (ru)
ZA (1) ZA201105436B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ594268A (en) * 2009-02-05 2013-05-31 Circassia Ltd Grass peptides for vaccine
EA027410B1 (ru) 2011-04-29 2017-07-31 Селекта Байосайенсиз, Инк. Наноносители, вызывающие иммунную толерантность, для снижения ответной реакции цитотоксических t-лимфоцитов
CN105338968A (zh) 2013-05-03 2016-02-17 西莱克塔生物科技公司 降低或预防响应于非变应原性抗原的过敏反应的致耐受性合成纳米载体
CA2957737A1 (en) 2014-09-07 2016-03-10 Selecta Biosciences, Inc. Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses
WO2017004561A1 (en) 2015-07-01 2017-01-05 Alk-Abelló A/S Peptide combinations and uses thereof for treating grass allergy
BR112019018748A2 (pt) 2017-03-11 2020-04-07 Selecta Biosciences Inc métodos e composições relacionados ao tratamento combinado com anti-inflamatórios e nanocarreadores sintéticos compreendendo um imunossupressor
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
CN108802216B (zh) * 2018-05-23 2021-04-16 山东出入境检验检疫局检验检疫技术中心 一种使用区域敏感性蛋白组和/或多肽组鉴别刺参产地的方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340729C (en) 1988-03-23 1999-09-07 Mohan Bir Singh Ryegrass pollen allergen
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
ATE159546T1 (de) 1990-08-17 1997-11-15 Univ Melbourne Allergene aus roggenspreupollen
WO1992016554A1 (en) 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
WO1994001560A1 (en) 1991-07-12 1994-01-20 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
CA2115579C (en) 1991-08-16 2008-03-25 Mohan Bir Singh Ryegrass pollen allergen
US6441157B1 (en) 1991-11-15 2002-08-27 University Of Melbourne Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon
CA2123210A1 (en) 1991-11-15 1993-05-27 Robert B. Knox Protein allergens of the species cynodon dactylon
NZ328940A (en) 1992-08-14 1999-05-28 Univ Melbourne Methods and use t cell epitopes of lol p v ryegrass pollen antigens
US6214358B1 (en) 1992-10-30 2001-04-10 Immulogic Pharamaceutical Corp. Protein allergens of the species Cynodon dactylon
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
EP0688338A1 (en) 1993-03-12 1995-12-27 Immulogic Pharmaceutical Corporation T cell epitopes of ryegrass pollen allergen
JPH09504167A (ja) * 1993-08-13 1997-04-28 イミュロジック ファーマスーティカル コーポレイション ドクムギ花粉アレルゲンのｔ細胞エピトープ
US5820862A (en) 1994-04-14 1998-10-13 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
GB9412714D0 (en) 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
WO1996003106A2 (en) * 1994-07-26 1996-02-08 University Of Manitoba Allergenic peptides derived from poa pratensis
US7112333B1 (en) 1994-08-05 2006-09-26 Heska Corporation T cell epitopes of ryegrass pollen allergen
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
AT402505B (de) 1995-08-02 1997-06-25 Biomay Prod & Handel Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.)
WO1999034826A1 (en) 1998-01-09 1999-07-15 Circassia Limited Methods and compositions for desensitisation
DE19823097A1 (de) * 1998-05-22 1999-11-25 Max Planck Gesellschaft Mittel gegen saisonale Typ-I-Allergien und bakterielle Infektionen
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
EP1453539B1 (en) 2001-12-05 2008-11-19 Circassia Limited Immunotherapeutic methods and systems
AUPS148202A0 (en) 2002-04-02 2002-05-09 Monash University Immunotherapeutic and immunoprophylactic reagents
WO2003088997A2 (en) 2002-04-22 2003-10-30 Universiteit Utrecht Holding B.V. Reduction of unwanted immune reactions
GB0210741D0 (en) 2002-05-10 2002-06-19 Medical Res Council Methods of therapy
GB0308988D0 (en) 2003-04-17 2003-05-28 Univ Singapore Molecule
DE102004035337A1 (de) 2004-07-21 2006-03-16 Merck Patent Gmbh Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität
WO2006075253A2 (en) 2005-01-11 2006-07-20 Commissariat A L'energie Atomique Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
EP1899367A4 (en) 2005-06-10 2009-06-24 Univ Singapore MUTANT ALLERGENS
DE202005009990U1 (de) * 2005-06-25 2006-11-02 Hengst Gmbh & Co.Kg Vorrichtung zum Abscheiden von Ölteilchen aus dem Kurbelgehäuseentlüftungsgas einer Brennkraftmaschine
US20070092532A1 (en) 2005-10-25 2007-04-26 Board Of Trustees Operating Michigan State University Arthritis vaccines and methods
JP5410759B2 (ja) 2005-11-29 2014-02-05 アクトジェニックス・エヌブイ 抗原に対する粘膜寛容の誘導
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
WO2008139163A1 (en) 2007-05-09 2008-11-20 Circassia Limited Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
CN101820907B (zh) * 2007-08-15 2013-05-01 切尔卡西亚有限公司 针对过敏原去敏化的肽
EP2042193A1 (en) 2007-09-28 2009-04-01 Biomay AG RNA Vaccines
EP2331124A1 (en) 2008-08-15 2011-06-15 Circassia Limited T-cell antigen peptide from allergen for stimulation of il-10 production
NZ594268A (en) * 2009-02-05 2013-05-31 Circassia Ltd Grass peptides for vaccine

Also Published As

Publication number Publication date
JP5746053B2 (ja) 2015-07-08
JP6215252B2 (ja) 2017-10-18
GB2469894A (en) 2010-11-03
IL214257A0 (en) 2011-09-27
CN103784952A (zh) 2014-05-14
ES2532759T3 (es) 2015-03-31
CN103784952B (zh) 2016-08-17
EP2393830B1 (en) 2015-01-28
AU2010212193A1 (en) 2011-08-18
PL2393830T3 (pl) 2015-07-31
NZ594268A (en) 2013-05-31
CA2751500A1 (en) 2010-08-12
EP2393830A1 (en) 2011-12-14
US20120148612A1 (en) 2012-06-14
EP2393830B8 (en) 2015-03-18
GB201001954D0 (en) 2010-03-24
MX2011008179A (es) 2011-09-09
US20140302071A1 (en) 2014-10-09
GB2469894B (en) 2011-09-07
ZA201105436B (en) 2012-09-26
KR20110111307A (ko) 2011-10-10
EA020792B1 (ru) 2015-01-30
WO2010089554A1 (en) 2010-08-12
BRPI1008802A2 (pt) 2016-03-08
CN102307893A (zh) 2012-01-04
SI2393830T1 (sl) 2015-04-30
JP2012516693A (ja) 2012-07-26
CN102307893B (zh) 2014-03-26
DK2393830T3 (en) 2015-04-27
AU2010212193B2 (en) 2015-05-14
WO2010089554A8 (en) 2011-10-06
JP2015180646A (ja) 2015-10-15
EP2891662A1 (en) 2015-07-08
PT2393830E (pt) 2015-04-23
SG173523A1 (en) 2011-09-29
US8753644B2 (en) 2014-06-17
HRP20150317T1 (hr) 2015-04-24
HK1212358A1 (en) 2016-06-10
IL214257A (en) 2016-06-30

Similar Documents

Publication Publication Date Title
CY1116828T1 (el) Πεπτιδια για απευαισθητοποιηση απο αλλεργιογονα
EA201171001A1 (ru) Пептиды трав для вакцины
DE602008002693D1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
MX2018016021A (es) Composiciones y metodos que comprenden variante de enzima lipolitica.
EA201001491A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
MX336737B (es) Composiciones y metodos que comprenden variantes de proteasa serina.
MX356282B (es) Composiciones y metodos que comprenden variantes de proteasa.
EA201001820A1 (ru) Новые иммуноадъювантные соединения на основе флагеллина и их применение
EA201170396A1 (ru) 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
DK2504353T4 (da) Lipopeptidsammensætninger og tilsvarende fremgangsmåder
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
UA108636C2 (xx) Пептид
EA201290792A1 (ru) Пептиды для вакцины против аллергии на березу
EA201201406A1 (ru) Фунгицидные смеси ii, содержащие хиназолины
MX2013004906A (es) Nuevos inhibidores especificos de la proteasa ns3 de hcv.
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
EA201171414A1 (ru) Ингибиторы белков семейства iap
EA201290243A1 (ru) Хиназолиновые соединения
IT1397446B1 (it) Compositions comprising amino acids for prevention and/or treatment of renal disorders.
UA110921C2 (uk) Пептид
PH12015501147A1 (en) Synbiotic composition and use thereof
MX2012012509A (es) Tapentadol para usarse en el tratamiento del sindrome del intestino irritable.
EA201201402A1 (ru) Фунгицидные смеси ii, содержащие хиназолины

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU